Proband-NFL Analysis

By Nirosen Vijiaratnam and Huw Morris
View Published Code

Output Details

Description
Code used for the manuscript "Combining biomarkers for prognostic modelling of Parkinson’s disease" by Niro Viijaratnam and colleagues.
Identifier (DOI)
10.5281/zenodo.5525370
Tags
  • Biomarkers
  • GBA (Glucocerebrosidase)
  • Predictive models
Team
Team Hardy
Program
Collaborative Research Network
Theme
PD Functional Genomics

Meet the Authors

  • User avatar fallback logo

    Nirosen Vijiaratnam

  • Huw Morris

    Collaborating PI: Team Hardy, 

    University College London

Related Research

Sample Collection and Measurement of Serum Neurofilament Light (NfL)

This protocol details the steps for the preparation of serum from human blood samples and the measurement of NfL concentration using the NF-Light Advantage kit on the HD-X Analyzer (Quanterix, Billerica, MA).

View Protocol

Diabetes and neuroaxonal damage in Parkinson’s disease

Our findings affirm Uyar et al's report of an association between PD-DM and more severe neuroaxonal damage. T2DM and PD share several pathological processes, in par mediated by hyperglycemia and possibly diabetic neuropathy.

View Article

Combining biomarkers for prognostic modelling of Parkinson’s disease

Parkinson's disease progression varies among patients. Predicting progression accurately is crucial for clinical trial selection. Blood biomarkers like serum NfL, along with genetic factors (GBA, APOE) can enhance prediction beyond age and phenotype.

View Article
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.